Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
13.63
-0.07 (-0.51%)
May 19, 2026, 10:25 AM CST
SHA:603108 Revenue
Shanghai Runda Medical Technology had revenue of 1.51B CNY in the quarter ending March 31, 2026, a decrease of -9.11%. This brings the company's revenue in the last twelve months to 6.85B, down -13.34% year-over-year. In the year 2025, Shanghai Runda Medical Technology had annual revenue of 7.00B, down -15.80%.
Revenue (ttm)
6.85B
Revenue Growth
-13.34%
P/S Ratio
1.21
Revenue / Employee
2.18M
Employees
3,137
Market Cap
8.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.00B | -1.31B | -15.80% |
| Dec 31, 2024 | 8.31B | -835.59M | -9.13% |
| Dec 31, 2023 | 9.15B | -1.35B | -12.84% |
| Dec 31, 2022 | 10.49B | 1.63B | 18.45% |
| Dec 31, 2021 | 8.86B | 1.79B | 25.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.98B |
| Guangzhou Kingmed Diagnostics Group | 5.91B |
| BGI Genomics | 3.84B |
| Maccura Biotechnology Co.Ltd | 2.14B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.19B |